Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting

Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting

Fernando Munayco-Guillén,1,2 Miguel Angel Vazquez-Membrillo,1,2 Marlon Rafael Garcia-Roa,1,2 Jhony Alberto De La Cruz-Vargas,3 Herney Andrés García-Perdomo,4 Rafael Pichardo-Rodriguez3 1Department of Retina and Vitreous Surgery, Instituto Mexicano de Oftalmología (IMO), Querétaro, México; 2Universid...

Full description

Bibliographic Details
Main Authors:	Munayco-Guillén F, Vazquez-Membrillo MA, Garcia-Roa MR, De La Cruz-Vargas JA, García-Perdomo HA, Pichardo-Rodriguez R
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-04-01
Series:	Clinical Ophthalmology
Subjects:	antiangiogenic diabetes mellitus intravitreal injection macular edema optical coherence tomography ziv-aflibercept
Online Access:	https://www.dovepress.com/effectiveness-of-the-use-of-three-dose-intravitreal-ziv-aflibercept-in-peer-reviewed-fulltext-article-OPTH

Similar Items

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016-09-01)

Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
by: Amin E. Nawar, et al.
Published: (2022-06-01)

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes
by: Siamak Moradian, et al.
Published: (2023-04-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial
by: Sinawat S, et al.
Published: (2023-09-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020-03-01)

Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
by: Mansour AM, et al.
Published: (2019-04-01)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
by: Xiu-Xian Wang, et al.
Published: (2021-12-01)

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
by: Imoro Z Braimah, et al.
Published: (2019-01-01)

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab
by: Mahmoud Alaa Abouhussein, et al.
Published: (2021-01-01)

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion
by: Mohab Eldeeb, et al.
Published: (2017-12-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)

Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
by: Julia de Lima Farah, et al.
Published: (2018-10-01)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021-05-01)

Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
by: Amin E. Nawar, et al.
Published: (2020-10-01)

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection
by: Sumit Randhir Singh, et al.
Published: (2018-01-01)

Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
by: Yawara Kikuchi, et al.
Published: (2022-10-01)

Short-term outcomes after the loading phase of intravitreal bevacizumab and subthreshold macular laser in non-center involved diabetic macular edema
by: Edgar Cuervo-Lozano, et al.
Published: (2018-06-01)

Aflibercept compared with dexamethasone in diabetic macular edema
by: Rodolfo Garretón, et al.
Published: (2021-05-01)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
by: Patricia Udaondo Mirete, et al.
Published: (2023-01-01)

Aflibercept versus dexamethasone for macular edema secondary to central retinal vein occlusion
by: Rodolfo Garretón, et al.
Published: (2019-12-01)

Aflibercept for macular edema after branch retinal vein occlusion
by: Mahmoud Abouhussein
Published: (2018-01-01)

Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems
by: Shinichiro Chujo, et al.
Published: (2020-09-01)

Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
by: Simone Donati, et al.
Published: (2023-11-01)

Short-term efficacy of intravitreal Aflibercept injection on macular edema secondary to retinal vein occlusion
by: Zhi-Peng Yan, et al.
Published: (2020-07-01)

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data
by: Dominic Muston, et al.
Published: (2018-12-01)

Comparative study between ranibizumab and aflibercept in the management of macular edema caused by diabetes mellitus in age group more than 40 years
by: Abd El-Magid M Tag El-Din
Published: (2019-01-01)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Alper Halil Bayat, et al.
Published: (2019-12-01)

Efficacy of Aflibercept and Ranibizumab in the treatment of diabetic macular edema
by: Bing Wu, et al.
Published: (2023-08-01)

Aflibercept monotherapy or bevacizumab first for diabetic macular edema
by: Avner Hostovsky, et al.
Published: (2024-01-01)

The effects of intravitreal adalimumab injection on pseudophakic macular edema
by: Mohsen Farvardin, et al.
Published: (2020-07-01)

Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
by: Hakan Koc, et al.
Published: (2023-03-01)

Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01)

Long-Term Management of Complications of Retinal Artery Macroaneurysms with Intravitreal Aflibercept Injection
by: Kamal Kishore
Published: (2016-09-01)

A combination of suprachoroidal injection of triamcinolone using a custom-made needle and intravitreal Ziv-aflibercept every eight weeks to manage naïve/denovo central DME: a single-center retrospective case series
by: Ameen Marashi, et al.
Published: (2024-04-01)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
by: Cai S, et al.
Published: (2018-10-01)

Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
by: Joshi L, et al.
Published: (2016-10-01)

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
by: Campos Polo R, et al.
Published: (2018-01-01)